Full name
HYBRIDOVAX SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | -0,5 | 0 | 100 |
EBITDA | -0,5 | 0 | 100 |
Short time liabilities | 0,5 | 0,5 | 0 |
Equity capital | 4,5 | 4,5 | 0 |
Operating profit (EBIT) | -0,5 | 0 | 100 |
Assets | 5 | 5 | 0 |
Net profit (loss) | -0,5 | 0 | 100 |
Cash | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0,5 | 0,5 | 0 |
Working assets | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | -10,9 | 0 | 10,9 |
Equity capital to total assets | 90,2 | 90,2 | 0 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0 | 0 | 0 |
Net dept to EBITDA | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane